Lee's Pharmaceutical Holdings Ltd. Stock: price and insider trades · Hong Kong
1 insider bought €26k of shares over the last 90 days, the latest by Leelalertsuphakun Wanee, filed 24 Sept 2026.
Lee's Pharmaceutical Holdings Ltd.: what insiders have been doing
This page follows insider dealings at Lee's Pharmaceutical Holdings Ltd. as filed with HKEX based in Hong Kong. From 19 October 2025 to 19 October 2026, the disclosure feed for Lee's Pharmaceutical Holdings Ltd. logged 7 filings by 2 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 7 purchases totalling €87k. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 2 senior executives. Leelalertsuphakun Wanee filed the largest purchase, €26k, on 24 September 2026, which represents 0.037% of the company's market value.
Compared with its exchange (1,147 companies, median 5 filings), a count of 7 filings is above the norm. Our records for Lee's Pharmaceutical Holdings Ltd. go back to 2017, with 104 purchases and 48 sales on the open market in total.
The clock since the last published purchase (24 September 2026) now reads 45 days. Typically, a trade is published a median of 5 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.
This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Key facts
Headquarters: Hong Kong
Source: Wikidata (CC0).
Who traded when
BuySaleSince the insiders bought
- -12.8%Entry HK$1.21 · Close 16 Oct 2026 HK$1.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 206,000 shares@ HK$1.150.037% mcap30.2% of flowShareXHKGHKEX:DA20260924E00149Canonical exit: 16 Dec 2026 (T+90)
- 81,500 shares@ HK$1.0610.9% of flowShareXHKGHKEX:DA20260608E00031Canonical exit: 3 Sept 2026 (T+90)
- 200,000 shares@ HK$1.0827.2% of flowShareXHKGHKEX:DA20260608E00030Canonical exit: 2 Sept 2026 (T+90)
- 200,000 shares@ HK$1.040.032% mcap26.1% of flowShareXHKGHKEX:DA20260603E00007Canonical exit: 26 Aug 2026 (T+90)
- 41,500 shares@ HK$1.060.0067% mcap5.5% of flowShareXHKGHKEX:DA20260603E00006Canonical exit: 27 Aug 2026 (T+90)
- 588,000 sharesShareXHKGHKEX:DA20251020E00477Canonical exit: 13 Jan 2026 (T+90)
- 588,000 sharesShareXHKGHKEX:DA20251020E00487Canonical exit: 13 Jan 2026 (T+90)
- 22,500 shares@ HK$1.39ShareXHKGHKEX:DA20250522E00360Canonical exit: 17 Aug 2025 (T+90)
- 61,500 shares@ HK$1.39ShareXHKGHKEX:DA20250522E00359Canonical exit: 14 Aug 2025 (T+90)
- 56,500 shares@ HK$1.1762ShareXHKGHKEX:DA20240920E00228Canonical exit: 12 Dec 2024 (T+90)
- 50,000 shares@ HK$1.14ShareXHKGHKEX:DA20240713E00009Canonical exit: 7 Oct 2024 (T+90)
- 52,000 shares@ HK$1.1303ShareXHKGHKEX:DA20240713E00008Canonical exit: 6 Oct 2024 (T+90)
- 100,000 shares@ HK$1.165ShareXHKGHKEX:DA20240705E00046Canonical exit: 26 Sept 2024 (T+90)
- 100,000 shares@ HK$1.20ShareXHKGHKEX:DA20240619E00294Canonical exit: 17 Sept 2024 (T+90)
- 72,500 shares@ HK$1.1438ShareXHKGHKEX:DA20240619E00293Canonical exit: 15 Sept 2024 (T+90)
- 7,500 shares@ HK$1.21ShareXHKGHKEX:DA20240611E00577Canonical exit: 9 Sept 2024 (T+90)
- 50,000 shares@ HK$1.22ShareXHKGHKEX:DA20240611E00576Canonical exit: 5 Sept 2024 (T+90)
- 50,000 shares@ HK$1.22ShareXHKGHKEX:DA20240611E00575Canonical exit: 4 Sept 2024 (T+90)
- 33,500 shares@ HK$1.18ShareXHKGHKEX:DA20240508E00153Canonical exit: 1 Aug 2024 (T+90)
- 114,000 shares@ HK$1.1447ShareXHKGHKEX:DA20240508E00152Canonical exit: 31 Jul 2024 (T+90)
- 7,000 shares@ HK$1.0993ShareXHKGHKEX:DA20240508E00151Canonical exit: 29 Jul 2024 (T+90)
- 50,000 shares@ HK$1.37ShareXHKGHKEX:DA20240126E00090Canonical exit: 24 Apr 2024 (T+90)
- 30,000 shares@ HK$1.3543ShareXHKGHKEX:DA20240126E00089Canonical exit: 22 Apr 2024 (T+90)
- 90,000 shares@ HK$1.3693ShareXHKGHKEX:DA20240123E00565Canonical exit: 19 Apr 2024 (T+90)
- 538,000 sharesShareXHKGHKEX:DA20240123E00573
25 of 152 declarations
About Lee's Pharmaceutical Holdings Ltd.
Lee's Pharmaceutical Holdings Ltd. is a Hong Kong-based pharmaceutical company focused on the development and commercialization of drugs. It specializes in treatments for respiratory diseases, infectious diseases, and metabolic disorders.